Transgender at the Cancer Clinic

A transgender patient leads a doctor and his fellow to re-examine the traditional rigid rules of medicine and step outside their comfort zone when the issue of sexual orientation enters the exam room.

Hope and Reality

When discussing prognosis and treatment options with older leukemia patients, should the focus be on the 10 percent who will survive long-term or the 90 percent who won’t? By trying to prepare patients, do doctors risk dashing their hopes? Mikkael Sekeres, MD, MS, Director of Cleveland Clinic’s Leukemia Program, mulls those difficult questions in his New York Times column.

Resetting the Clock

For adults with leukemia, five years of disease-free survival technically constitutes a cure. But how should doctor and patient view reaching this milestone? Cautiously, writes oncologist Mikkael Sekeres, MD, MS, Director of Cleveland Clinic’s Leukemia Program, in his New York Times column.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy